Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data by Andrew E. Dellinger, Andrew B. Nixon, Herbert Pang

Get full text

Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data by Andrew E. Dellinger, Andrew B. Nixon, Herbert Pang

Get full text

Endoglin Targeting: Lessons Learned and Questions That Remain by Yingmiao Liu, Madelon Paauwe, Andrew B. Nixon, Lukas J.A.C. Hawinkels

Get full text

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? by Andrew B. Nixon, Kurt A. Schalper, Ira Jacobs, Shobha Potluri, I-Ming Wang, Catherine Fleener

Get full text

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) by Hyung L. Kim, Susan Halabi, Ping Li, Greg Mayhew, Jeff Simko, Andrew B. Nixon, Eric J. Small, Brian Rini, Michael J. Morris, Mary-Ellen Taplin, Daniel George

Get full text

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations by Sarah E. Wetzel-Strong, Shantel Weinsheimer, Jeffrey Nelson, Ludmila Pawlikowska, Dewi Clark, Mark D. Starr, Yingmiao Liu, Helen Kim, Marie E. Faughnan, Andrew B. Nixon, Douglas A. Marchuk

Get full text

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial by Manmeet S. Ahluwalia, Lisa R. Rogers, Rekha Chaudhary, Herbert Newton, Ahmad Ozair, Atulya A. Khosla, Andrew B. Nixon, Bonne J. Adams, Ben K. Seon, David M. Peereboom, Charles P. Theuer

Get full text

Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers by Ben Horst, Shrikant Pradhan, Roohi Chaudhary, Eduardo Listik, Liz Quintero-Macias, Alex Seok Choi, Michael Southard, Yingmiao Liu, Regina Whitaker, Nadine Hempel, Andrew Berchuck, Andrew B. Nixon, Nam Y. Lee, Yoav I. Henis, Karthikeyan Mythreye

Get full text

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia. by Sharareh Siamakpour-Reihani, Felicia Cao, Jing Lyu, Yi Ren, Andrew B Nixon, Jichun Xie, Amy T Bush, Mark D Starr, James R Bain, Michael J Muehlbauer, Olga Ilkayeva, Virginia Byers Kraus, Janet L Huebner, Nelson J Chao, Anthony D Sung

Get full text

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia by Sharareh Siamakpour-Reihani, Felicia Cao, Jing Lyu, Yi Ren, Andrew B. Nixon, Jichun Xie, Amy T. Bush, Mark D. Starr, James R. Bain, Michael J. Muehlbauer, Olga Ilkayeva, Virginia Byers Kraus, Janet L. Huebner, Nelson J. Chao, Anthony D. Sung

Get full text

Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer by Alex S. Choi, Laura M. Jenkins-Lane, Wade Barton, Asha Kumari, Carly Lancaster, Calen Raulerson, Hao Ji, Diego Altomare, Mark D. Starr, Regina Whitaker, Rebecca Phaeton, Rebecca Arend, Michael Shtutman, Andrew B. Nixon, Nadine Hempel, Nam Y. Lee, Karthikeyan Mythreye

Get full text

Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer by Zainab Shonibare, Mehri Monavarian, Kathleen O’Connell, Diego Altomare, Abigail Shelton, Shubham Mehta, Renata Jaskula-Sztul, Rebecca Phaeton, Mark D. Starr, Regina Whitaker, Andrew Berchuck, Andrew B. Nixon, Rebecca C. Arend, Nam Y. Lee, C. Ryan Miller, Nadine Hempel, Karthikeyan Mythreye

Get full text

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial by Jeffrey M. Clarke, MD, Lin Gu, MS, Xiaofei F. Wang, PhD, Thomas E. Stinchcombe, MD, Marvaretta M. Stevenson, MD, Sundhar Ramalingam, MD, Afreen Shariff, MD, Jennifer Garst, MD, Andrew B. Nixon, PhD, Scott J. Antonia, MD, Jeffrey Crawford, MD, Neal E. Ready, MD, PhD

Get full text

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer by Michael N. Corradetti, MD, PhD, Jordan A. Torok, MD, Ace J. Hatch, PhD, Eric P. Xanthopoulos, MD, JD, Kyle Lafata, PhD, Corbin Jacobs, MD, Christel Rushing, MA, John Calaway, PhD, Greg Jones, MS, Chris R. Kelsey, MD, Andrew B. Nixon, PhD

Get full text